In brief

BMJ 2012; 344 doi: (Published 17 January 2012) Cite this as: BMJ 2012;344:e459

China is to tighten rules on stem cell therapy: China’s health ministry will regulate all stem cell therapy research and clinical practice within one year, the official news agency Xinhua reports. Thousands of overseas patients travel to China for unregulated stem cell therapy to treat diseases such as diabetes, spinal cord injury, cerebral palsy, brain injury, and stroke.

US watchdog calls for new vote on drug’s safety: The not for profit Project on Government Oversight is calling on …

View Full Text

Log in

Log in through your institution


* For online subscription